Breast Neoplasms Clinical Trial Using Trastuzumab, pertuzumab and lapatinib

- The folks at UNC Lineberger Comprehensive Cancer Center are studying the effects of Trastuzumab; pertuzumab; lapatinib on Breast Neoplasms in females ages 18 years and older. This clinical trial is slated to start September 2013 and is expected to end circa May 2016.

Rachel Phipps, RN
Overall Study Contact Info
StatusName Contact Phone
RecruitingRachel Phipps, RNrachel_phipps@med.unc.edu919-843-7197

This study is officially titled, "Defining the HER2 Positive (+) Breast Cancer Kinome Response to Trastuzumab, Pertuzumab, Combination Trastuzumab +Pertuzumab, or Combination Trastuzumab + Lapatinib."


University of Alabama at Birmingham

Birmingham, Alabama - Recruiting

Dana Farber Cancer Institute

Boston, Massachusetts - Recruiting

Lineberger Comprehensive Cancer Center, UNC

Chapel Hill, North Carolina - Recruiting

For more study details, please visit this link to record, which is the source of this webpage.